Rocuronium Bromide
Specifications
119302-91-9CAS Number
601-597-6EC Number
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromideIUPAC Name
C32H53BrN2O4Chemical Formula
609.7 g/molMolecular Weight
ROCURONIUM BROMIDE; 119302-91-9; ORG 9426; Org-9426; DTXSID7023566; I65MW4OFHZ; bromuro de rocuronio; bromure de rocuronium; org9426; Pyrrolidinium, 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide; CHEBI:8885; DTXCID503566; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide; Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide; rocuronii bromidum; ((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl) acetate;bromide; RefChem:56464; M03AC09; Zemuron; Esmeron; Rocuronium (Bromide); MFCD00867768; 1-Allyl-1-(3alpha,17beta-dihydroxy-2beta-morpholino-5alpha-androstan-16beta-yl)pyrrolidinium bromide, 17-acetate; C32H53BrN2O4; NCGC00167433-01; UNII-I65MW4OFHZ; Eslax; Rocuronium bromide; 1-[17ss-(Acetyloxy)-3a-hydroxy-2ss-(morpholin-4-yl)-5a-androstan-16ss-yl]-1-(prop-2-enyl)pyrrolidinium bromide; Zemuron (TN); Rocuronium bromide CRS; Rocuronium bromide [USAN:USP:INN:BAN]; SCHEMBL41320; orb1226839; orb1310887; (+)-ROCURONIUM BROMIDE; ROCURONIUM BROMIDE [MI]; CHEMBL1200648; ROCURONIUM BROMIDE [INN]; ROCURONIUM BROMIDE [JAN]; ROCURONIUM BROMIDE [USAN]; GLXC-03035; HMS3884O13; ROCURONIUM BROMIDE [VANDF]; ROCURONIUM BROMIDE [MART.]; Rocuronium bromide (JAN/USP/INN); ROCURONIUM BROMIDE [USP-RS]; ROCURONIUM BROMIDE [WHO-DD]; Tox21_112437; EBC-11243; AKOS025149635; Rocuronium for peak identification CRS; AC-2004; CCG-270222; CS-1467; FR27748; ROCURONIUM BROMIDE [ORANGE BOOK]; NCGC00167433-08; ROCURONIUM BROMIDE [EP MONOGRAPH]; 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium bromide; 111GE014; AS-13323; BR177300; HY-17440; ROCURONIUM BROMIDE [USP MONOGRAPH]; SY103602; CAS-119302-91-9; R0099; R5611; D00765; Q27108171; Rocuronium bromide, >=98% (perchloric acid titration); Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard; Rocuronium bromide, United States Pharmacopeia (USP) Reference Standard; Rocuronium for peak identification, European Pharmacopoeia (EP) Reference Standard; (2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-morpholin-4-yl-16-(1-prop-2-en-1-ylpyrrolidinium-1-yl)androstane bromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromideEE; 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(4-morpholinyl)-androstan-16-yl]-1(2-propenyl)pyrrolidinium bromide; 1-[17|A-(Acetyloxy)-3|A-hydroxy-2|A-(morpholin-4-yl)-5|A-androstan-16|A-yl]-1-(prop-2-enyl)pyrrolidinium bromide; 1-[17beta-acetyloxy-3alpha-hydroxy-2beta-(4-morpholinyl)-5alpha-androstan-16beta-yl]-1-(2-propenyl)pyrrolidinium bromide; 17beta-(Acetyloxy)-3alpha-hydroxy-2beta-(morpholin-4-yl)-16beta-[1-(prop-2-en-1-yl)pyrrolidin-1-ium-1-yl]-5alpha-androstane bromide; 17beta-(acetyloxy)-3alpha-hydroxy-2beta-(morpholin-4-yl)-16beta-[1-(prop-2-en-1-yl)pyrrolidinium-1-yl]-5alpha-androstane; 17beta-acetoxy-16beta-(1-allylpyrrolidinium-1-yl)-3alpha-hydroxy-2beta-(morpholin-4-yl)-5alphaandrostane; PYRROLIDINIUM, 1-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-17-(ACETYLOXY)-3-HYDROXY-2-(4-MORPHOLINYL)ANDROSTAN-16-YL)-1-(2-PROPENYL)-, BROMIDE; Pyrrolidinium, 1-[(2|_,3|_,5|_,16|_,17|_)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide; Pyrrolidinium, 1-[(2|A,3|A,5|A,16|A,17|A)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromideSynonyms
Products Containing Rocuronium Bromide
로큐바주(로쿠로늄브롬화물수화물)로니움주사(로쿠로늄브롬화물)카비로쿠로니움주(로쿠로니움브롬화물)로크니움주(로쿠로늄브롬화물)로카론주(로쿠로늄브롬화물)로큐메론주(로쿠로늄브롬화물)로큐니움주사(로쿠로늄브롬화물)로큐론주(로쿠로늄브롬화물)로메론주사(로쿠로늄브롬화물)큐로니주(로쿠로늄브롬화물)에스메론주(로쿠로늄브롬화물)ROCURONIO TAMARANG 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG
Page 1 of 6
Companies Selling Rocuronium Bromide
(주
(주)휴온스Republic of Korea동국
동국제약(주)Republic of Korea한림
한림제약(주)Republic of Korea일성
일성아이에스(주)Republic of Korea(주
(주)비씨월드제약Republic of KoreaPage 1 of 5